{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:49:54Z","timestamp":1791942594516,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K12625"],"award-info":[{"award-number":["25K12625"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03070"],"award-info":[{"award-number":["21H03070"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama121052 and JP25ama121054"],"award-info":[{"award-number":["JP25ama121052 and JP25ama121054"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22jm0210085, JP22am0401007, and JP22ym0126804"],"award-info":[{"award-number":["JP22jm0210085, JP22am0401007, and JP22ym0126804"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02847-6","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:16:53Z","timestamp":1784297813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-1889","authenticated-orcid":false,"given":"Takuya","family":"Tsujino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritoshi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Maenosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Hirosuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-7664","authenticated-orcid":false,"given":"Kazuki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Higashio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5015-7694","authenticated-orcid":false,"given":"Keita","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiju","family":"Shimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-5262","authenticated-orcid":false,"given":"Fumihito","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nihei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Osuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4017-1157","authenticated-orcid":false,"given":"Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-7281","authenticated-orcid":false,"given":"Akihide","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhito","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"2847_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/JU.0000000000003981","volume":"212","author":"J Holzbeierlein","year":"2024","unstructured":"Holzbeierlein, J. et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; amended 2020, 2024). J. Urol. 212, 3\u201310 (2024).","journal-title":"J. Urol."},{"key":"2847_CR2","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1200\/JCO.2014.57.5548","volume":"32","author":"RH Mak","year":"2014","unstructured":"Mak, R. H. et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J. Clin. Oncol. 32, 3801\u20133809 (2014).","journal-title":"J. Clin. Oncol."},{"key":"2847_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta, A. R. et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol. 24, 669\u2013681 (2023).","journal-title":"Lancet Oncol."},{"key":"2847_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/djaa095","volume":"113","author":"KL Pitter","year":"2021","unstructured":"Pitter, K. L. et al. Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy. J. Natl. Cancer Inst. 113, 266\u2013273 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"2847_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"FJ Groelly","year":"2023","unstructured":"Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N. & Tarsounas, M. Targeting DNA damage response pathways in cancer. Nat. Rev. Cancer 23, 78\u201394 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2847_CR6","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1158\/1078-0432.CCR-23-0792","volume":"29","author":"SC Kamran","year":"2023","unstructured":"Kamran, S. C. et al. Genomic tumor correlates of clinical outcomes following organ-sparing chemoradiation therapy for bladder cancer. Clin. Cancer Res. 29, 5116\u20135127 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2847_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18, 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2847_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, X., Jin, S., Chen, Y. & Guo, R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer 21, 47 (2022).","journal-title":"Mol. Cancer"},{"key":"2847_CR9","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1038\/s41388-021-01790-w","volume":"40","author":"G Lei","year":"2021","unstructured":"Lei, G. et al. Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity. Oncogene 40, 3533\u20133547 (2021).","journal-title":"Oncogene"},{"key":"2847_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer 22, 381\u2013396 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2847_CR11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos, A. F., Fazeli, G., Xavier da Silva, T. N. & Friedmann Angeli, J. P. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 33, 1062\u20131076 (2023).","journal-title":"Trends Cell Biol."},{"key":"2847_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42, 513\u2013534 (2024).","journal-title":"Cancer Cell"},{"key":"2847_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02337-3","volume":"24","author":"S Bhowmick","year":"2025","unstructured":"Bhowmick, S., Banerjee, S., Shridhar, V. & Mondal, S. Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance. Mol. Cancer 24, 161 (2025).","journal-title":"Mol. Cancer"},{"key":"2847_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2847_CR15","doi-asserted-by":"publisher","first-page":"175497","DOI":"10.1016\/j.ejphar.2023.175497","volume":"941","author":"J Lee","year":"2023","unstructured":"Lee, J., Shin, D. & Roh, J. L. Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance. Eur. J. Pharm. 941, 175497 (2023).","journal-title":"Eur. J. Pharm."},{"key":"2847_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"2847_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl9794","volume":"8","author":"C Miao","year":"2022","unstructured":"Miao, C. et al. RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Sci. Adv. 8, eabl9794 (2022).","journal-title":"Sci. Adv."},{"key":"2847_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35880-y","volume":"14","author":"T Tsujino","year":"2023","unstructured":"Tsujino, T. et al. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nat. Commun. 14, 252 (2023).","journal-title":"Nat. Commun."},{"key":"2847_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","volume":"631","author":"GS Franca","year":"2024","unstructured":"Franca, G. S. et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature 631, 876\u2013883 (2024).","journal-title":"Nature"},{"key":"2847_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116191","volume":"44","author":"JA Guo","year":"2025","unstructured":"Guo, J. A. et al. Integrative genomic identification of therapeutic targets for pancreatic cancer. Cell Rep. 44, 116191 (2025).","journal-title":"Cell Rep."},{"key":"2847_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun, A. et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur. Urol. 77, 420\u2013433 (2020).","journal-title":"Eur. Urol."},{"key":"2847_CR22","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca, B. A. et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell 184, 5482\u20135496.e5428 (2021).","journal-title":"Cell"},{"key":"2847_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello, F. et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 11, 34 (2019).","journal-title":"Genome Med."},{"key":"2847_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"2847_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176124","volume":"961","author":"W Zhu","year":"2023","unstructured":"Zhu, W. et al. Ferroptosis and tumor immunity: in perspective of the major cell components in the tumor microenvironment. Eur. J. Pharm. 961, 176124 (2023).","journal-title":"Eur. J. Pharm."},{"key":"2847_CR26","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"Zhou, N. et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 51, D571\u2013D582 (2023).","journal-title":"Nucleic Acids Res."},{"key":"2847_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416.e411 (2018).","journal-title":"Cell"},{"key":"2847_CR28","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sjodahl","year":"2012","unstructured":"Sjodahl, G. et al. A molecular taxonomy for urothelial carcinoma. Clin. Cancer Res. 18, 3377\u20133386 (2012).","journal-title":"Clin. Cancer Res."},{"key":"2847_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/path.4886","volume":"242","author":"G Sjodahl","year":"2017","unstructured":"Sjodahl, G., Eriksson, P., Liedberg, F. & Hoglund, M. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification. J. Pathol. 242, 113\u2013125 (2017).","journal-title":"J. Pathol."},{"key":"2847_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/path.6062","volume":"259","author":"M Hoglund","year":"2023","unstructured":"Hoglund, M. et al. The Lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again. J. Pathol. 259, 369\u2013375 (2023).","journal-title":"J. Pathol."},{"key":"2847_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat. Commun. 12, 1589 (2021).","journal-title":"Nat. Commun."},{"key":"2847_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B. & Conrad, M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic. Biol. Med. 133, 144\u2013152 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"2847_CR33","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41556-025-01722-w","volume":"27","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis. Nat. Cell Biol. 27, 1288\u20131300 (2025).","journal-title":"Nat. Cell Biol."},{"key":"2847_CR34","doi-asserted-by":"publisher","first-page":"102457","DOI":"10.1016\/j.xpro.2023.102457","volume":"4","author":"MB Murray","year":"2023","unstructured":"Murray, M. B., Leak, L. B., Lee, W. C. & Dixon, S. J. Protocol for detection of ferroptosis in cultured cells. STAR Protoc. 4, 102457 (2023).","journal-title":"STAR Protoc."},{"key":"2847_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/iju.70341","volume":"33","author":"T Iwasawa","year":"2026","unstructured":"Iwasawa, T. et al. Translational advances in urothelial carcinoma: from bench to bedside. Int J. Urol. 33, e70341 (2026).","journal-title":"Int J. Urol."},{"key":"2847_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1200\/JCO-24-01214","volume":"43","author":"DM Geynisman","year":"2025","unstructured":"Geynisman, D. M. et al. Phase II trial of risk-enabled therapy after neoadjuvant chemotherapy for muscle-invasive bladder cancer (RETAIN 1). J. Clin. Oncol. 43, 1113\u20131122 (2025).","journal-title":"J. Clin. Oncol."},{"key":"2847_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01897-6","volume":"22","author":"K Komura","year":"2023","unstructured":"Komura, K. et al. The impact of FGFR3 alterations on the tumor microenvironment and the efficacy of immune checkpoint inhibitors in bladder cancer. Mol. Cancer 22, 185 (2023).","journal-title":"Mol. Cancer"},{"key":"2847_CR38","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","volume":"6","author":"JM Ubellacker","year":"2025","unstructured":"Ubellacker, J. M. & Dixon, S. J. Prospects for ferroptosis therapies in cancer. Nat. Cancer 6, 1326\u20131336 (2025).","journal-title":"Nat. Cancer"},{"key":"2847_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41462-9","volume":"14","author":"M Oh","year":"2023","unstructured":"Oh, M. et al. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat. Commun. 14, 5728 (2023).","journal-title":"Nat. Commun."},{"key":"2847_CR40","doi-asserted-by":"crossref","unstructured":"Wang, J., Guo, D., Jiang, S., Wu, W. & Gao, X. Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. Mol. Biomed. 7, 20 (2026).","DOI":"10.1186\/s43556-026-00416-5"},{"key":"2847_CR41","doi-asserted-by":"crossref","unstructured":"Guo, F. et al. Ferroptosis and metastasis: molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities. Mol Cancer 25, 45 (2026).","DOI":"10.1186\/s12943-025-02544-y"},{"key":"2847_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/cas.14224","volume":"111","author":"Y Otsuki","year":"2020","unstructured":"Otsuki, Y. et al. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy. Cancer Sci. 111, 127\u2013136 (2020).","journal-title":"Cancer Sci."},{"issue":"Suppl 4","key":"2847_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1464-410X.2012.11476.x","volume":"110","author":"N Sapre","year":"2012","unstructured":"Sapre, N., Anderson, P. & Foroudi, F. Management of local recurrences in the irradiated bladder: a systematic review. BJU Int. 110(Suppl 4), 51\u201357 (2012).","journal-title":"BJU Int."},{"key":"2847_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma. 12, 77 (2011).","journal-title":"BMC Bioinforma."},{"key":"2847_CR45","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397 (2013).","journal-title":"Stat. Med."},{"key":"2847_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genom. Proteom. Bioinforma. 20, 587\u2013596 (2022).","journal-title":"Genom. Proteom. Bioinforma."},{"key":"2847_CR47","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nbt.3758","volume":"35","author":"N Yachie","year":"2017","unstructured":"Yachie, N., Robotic Biology, C. & Natsume, T. Robotic crowd biology with Maholo LabDroids. Nat. Biotechnol. 35, 310\u2013312 (2017).","journal-title":"Nat. Biotechnol."},{"key":"2847_CR48","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai, H. et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int. J. Cancer 149, 2099\u20132115 (2021).","journal-title":"Int. J. Cancer"},{"key":"2847_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02847-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:02:01Z","timestamp":1784304121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2847"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02847-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All the authors, by giving their consent to participate, have given their consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"299"}}